Ambulatory oxygen: Why do COPD patients not use their portable systems as prescribed? A qualitative study

BMC Pulmonary Medicine

Volumn 11, Issue , 2011, Pages

  Arnold, Elizabeth ^a,b   Bruton, Anne ^a   Donovan Hall, Maggie ^a   Fenwick, Angela ^c   Dibb, Bridget ^d   Walker, Elizabeth ^e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d BRUNEL UNIVERSITY   (United Kingdom)

^e QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMBULATORY OXYGEN SYSTEM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROUNDED THEORY; HEALTH CARE PLANNING; HUMAN; INTERVIEW; LONG TERM CARE; MALE; NASOGASTRIC TUBE; OXYGEN THERAPY; PORTABLE EQUIPMENT; PRESCRIPTION; QUALITATIVE RESEARCH; UNITED KINGDOM; AMBULATORY CARE; EMOTION; HEALTH SURVEY; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME; UTILIZATION REVIEW;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; EMOTIONS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 79751533042     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-11-9     Document Type: Article

References (29)

1. Bridgelal RM, Grocott PR, Weir HC. Issues and challenges of involving users in medical device development. Health Expect 2008, 11:63-71. 10.1111/j.1369-7625.2007.00464.x, 18275403.
2. Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH) 2010, 20-2-2010, Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH)., http://www.match.ac.uk
3. Duck A. Cost-effectiveness and efficacy in long-term oxygen therapy. Nurs Times 2006, 102:46-50.
4. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir Med 2004, 98:285-293. 10.1016/j.rmed.2003.10.008, 15072168.
5. Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 2005, 25:1032-1038. 10.1183/09031936.05.00113504, 15929958.
6. Lehane E, McCarthy G. Medication non-adherence--exploring the conceptual mire. Int J Nurs Pract 2009, 15:25-31. 10.1111/j.1440-172X.2008.01722.x, 19187166.
7. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008, 3:371-384. 2629978, 18990964.
8. Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med 2006, 174:373-378. 10.1164/rccm.200507-1161WS, 2648117, 16614349.
9. Nonoyama ML, Brooks D, Guyatt GH, Goldstein RS. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med 2007, 176:343-349. 10.1164/rccm.200702-308OC, 17446339.
10. Drummond MB, Wise RA. Oxygen therapy in COPD: what do we know?. Am J Respir Crit Care Med 2007, 176:321-322. 10.1164/rccm.200705-682ED, 17675448.
11. Albert P, Calverley PM. Drugs (including oxygen) in severe COPD. Eur Respir J 2008, 31:1114-1124. 10.1183/09031936.00116707, 18448506.
12. Consultation on a strategy for services for chronic obstructive pulmonary disease (COPD) in England 2010, Ref Type: Internet Communication 17-3-2010, Consultation on a strategy for services for chronic obstructive pulmonary disease (COPD) in England.
13. Chiovitti RF, Piran N. Rigour and grounded theory research. J Adv Nurs 2003, 44:427-435. 10.1046/j.0309-2402.2003.02822.x, 14651715.
14. Bryant A, Charmaz K. Grounded Theory in historical perspective: an epistemological account. Handbook of grounded theory 2007, 31-57. London: Sage, Bryant A, Charmaz K.
15. May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ 2009, 339:b2803. 10.1136/bmj.b2803, 19671932.
16. Kennedy A, Rogers A, Bower P. Support for self care for patients with chronic disease. BMJ 2007, 335:968-970. 10.1136/bmj.39372.540903.94, 2071971, 17991978.
17. Petty TL, Bliss PL. Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the Nocturnal Oxygen Therapy Trial revisited). Respir Care 2000, 45:204-211.
18. Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:513-518. 10.1513/pats.200708-124ET, 2645328, 18453364.
19. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008, 63:831-838. 10.1136/thx.2007.086041, 18728206.
20. George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005, 128:3198-3204. 10.1378/chest.128.5.3198, 16304262.
21. Sommavilla B, Jorgensen C, Jensen K. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother 2008, 9:2223-2232. 10.1517/14656566.9.13.2223, 18710348.
22. Williams V, Bruton A, Ellis-Hill C, McPherson K. What really matters to patients living with chronic obstructive pulmonary disease? An exploratory study. Chron Respir Dis 2007, 4:77-85. 10.1177/1479972307078482, 17621574.
23. Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient's perspective. J Gen Intern Med 2002, 17:749-755. 10.1046/j.1525-1497.2002.20218.x, 1495112, 12390550.
24. Bury M. Chronic illness as biographical disruption. Sociol Health Illn 1982, 4:167-182. 10.1111/1467-9566.ep11339939, 10260456.
25. Scharloo M, Kaptein AA, Weinman JA, Willems LN, Rooijmans HG. Physical and psychological correlates of functioning in patients with chronic obstructive pulmonary disease. J Asthma 2000, 37:17-29. 10.3109/02770900009055425, 10724295.
26. Ringbaek T, Lange P, Viskum K. Compliance with LTOT and consumption of mobile oxygen. Respir Med 1999, 93:333-337. 10.1016/S0954-6111(99)90314-1, 10464899.
27. Vogiatzis I, Stratakos G, Simoes DC, Terzis G, Georgiadou O, Roussos C, et al. Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax 2007, 62:950-956. 10.1136/thx.2006.069310, 2117139, 17573449.
28. Berton E, Antonucci R, Palange P. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 2001, 56:418-422.
29. Veazie PJ, Cai S. A connection between medication adherence, patient sense of uniqueness, and the personalization of information. Med Hypotheses 2007, 68:335-342. 10.1016/j.mehy.2006.04.077, 17008025.